Kondziolka D, Duma C M, Lunsford L D
Department of Neurological Surgery, University of Pittsburgh School of Medicine, PA.
Acta Neurochir (Wien). 1994;127(1-2):85-90. doi: 10.1007/BF01808553.
Successful clinical outcomes are not achieved in all patients who undergo image-guided stereotactic surgery as the initial procedure in the management of brain abscess. We sought to define those factors related to management failure, so that the initial surgical approach could be selected using preoperative clinical or imaging criteria. We reviewed our twelve-year experience in 29 consecutive patients. Twenty-two (76%) patients had drainage of abscesses with purulent centers. Seven (24%) underwent lesion biopsy for diagnosis. Twelve patients (with abscesses > 3 cm in average diameter) underwent stereotactic insertion of drainage catheters. Ten patients (34%) had adverse risk factors including immunologic suppression after prior organ transplantation, chronic steroid therapy, prior antineoplastic chemotherapy, or retained foreign body. Microbiological identification of the causative organism was obtained in 22 patients; 6 patients had positive Gram stains without growth in culture (bacteriological diagnosis = 97%). Long-term clinical evaluation (up to 8.5 years, median 3 years) confirmed disease resolution after initial single-procedure stereotactic management in 21 patients (72%). Eventual abscess resolution occurred in an additional 6 patients (21%), all of whom required multiple procedures. Five patients died of complications of their systemic disease during the follow-up period. Fifteen of the 18 (83%) surviving patients who had no associated risk factors returned to their premorbid functional capacity. Factors associated with initial treatment failure included inadequate aspiration, lack of catheter drainage of larger abscesses, chronic immunosuppression, and insufficient antibiotic therapy.
在所有将影像引导立体定向手术作为脑脓肿治疗初始程序的患者中,并非都能取得成功的临床结果。我们试图确定与治疗失败相关的因素,以便能根据术前临床或影像学标准选择初始手术方法。我们回顾了连续29例患者的12年治疗经验。22例(76%)患者进行了有脓性中心的脓肿引流。7例(24%)患者接受了病变活检以明确诊断。12例平均直径>3 cm脓肿的患者接受了立体定向引流管置入。10例(34%)患者有不良风险因素,包括既往器官移植后的免疫抑制、长期类固醇治疗、既往抗肿瘤化疗或体内有异物留存。22例患者获得了致病微生物的微生物学鉴定结果;6例患者革兰氏染色阳性但培养无生长(细菌学诊断率=97%)。长期临床评估(最长8.5年,中位时间3年)证实,21例(72%)患者在初始单次立体定向治疗后疾病得到缓解。另有6例患者(21%)最终脓肿消退,所有这些患者均需多次手术。5例患者在随访期间死于全身性疾病并发症。18例无相关风险因素的存活患者中有15例(83%)恢复到病前的功能状态。与初始治疗失败相关的因素包括抽吸不充分、较大脓肿缺乏导管引流、慢性免疫抑制以及抗生素治疗不足。